Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 15.63% is in line with its 5-year average of 16.73%, around the middle of its 5-year range (8.17%–19.07%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.98% below its 12-month average of 16.28%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 15.63%.
RETURN ON EQUITY (ROE)
15.63%
RETURN ON EQUITY (ROE) AVG TTM
16.28%
RETURN ON EQUITY (ROE) AVG 3Y
16.54%
RETURN ON EQUITY (ROE) AVG 5Y
16.73%
RETURN ON EQUITY (ROE) AVG 10Y
11.93%
RETURN ON EQUITY (ROE) AVG 15Y
12.11%
RETURN ON EQUITY (ROE) AVG 20Y
12.96%
CURRENT VS TTM AVG
-3.98%
CURRENT VS 3Y AVG
-5.47%
CURRENT VS 5Y AVG
-6.55%
CURRENT VS 10Y AVG
+31.00%
CURRENT VS 15Y AVG
+29.06%
CURRENT VS 20Y AVG
+20.66%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+137.21%
vs the sector median at left
UFP Technologies, Inc.
Market Cap
$2.34B
Return on Equity (ROE)
15.63%
TTM Avg
16.28%
3Y Avg
16.54%
5Y Avg
16.73%
Market Cap
$2.35B
Return on Equity (ROE)
-84.78%
TTM Avg
-42.91%
3Y Avg
-54.25%
5Y Avg
-44.36%
Market Cap
$2.36B
Return on Equity (ROE)
41.39%
TTM Avg
43.71%
3Y Avg
5.79%
5Y Avg
-18.90%
Market Cap
$2.37B
Return on Equity (ROE)
-38.17%
TTM Avg
-26.66%
3Y Avg
-25.50%
5Y Avg
23.47%
Market Cap
$2.30B
Return on Equity (ROE)
71.04%
TTM Avg
-161.38%
3Y Avg
-133.53%
5Y Avg
-111.86%
Market Cap
$2.38B
Return on Equity (ROE)
-4.88%
TTM Avg
-20.16%
3Y Avg
-52.49%
5Y Avg
-49.61%
Market Cap
$2.28B
Return on Equity (ROE)
18.14%
TTM Avg
20.16%
3Y Avg
28.24%
5Y Avg
15.58%
Market Cap
$2.43B
Return on Equity (ROE)
-56.71%
TTM Avg
-50.91%
3Y Avg
-55.48%
5Y Avg
-35.68%
Market Cap
$2.24B
Return on Equity (ROE)
N/A
TTM Avg
9.38%
3Y Avg
9.38%
5Y Avg
9.38%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| UFP Technologies, Inc. (UFPT) | $2.34B | 15.63% | 16.28% | 16.54% | 16.73% |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.35B | -84.78% | -42.91% | -54.25% | -44.36% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 41.39% | 43.71% | 5.79% | -18.90% |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | -38.17% | -26.66% | -25.50% | 23.47% |
| Liquidia Corporation (LQDA)vs › | $2.30B | 71.04% | -161.38% | -133.53% | -111.86% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.38B | -4.88% | -20.16% | -52.49% | -49.61% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 18.14% | 20.16% | 28.24% | 15.58% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | -56.71% | -50.91% | -55.48% | -35.68% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.24B | N/A | 9.38% | 9.38% | 9.38% |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.49B | -10.66% | 1.75% | 2.62% | 5.68% |
ROE
15.6%
ROA
10.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 15.63% |
| 2026-03-31 | 15.64% |
| 2025-12-31 | 16.12% |
| 2025-09-30 | 16.62% |
| 2025-06-30 | 17.41% |
| 2025-03-31 | 17.60% |
| 2024-12-31 | 17.21% |
| 2024-09-30 | 16.47% |
| 2024-06-30 | 15.97% |
| 2024-03-31 | 16.23% |
| 2023-12-31 | 15.70% |
| 2023-09-30 | 15.34% |
| 2023-06-30 | 19.07% |
| 2023-03-31 | 18.93% |
| 2022-12-31 | 17.59% |
| 2022-09-30 | 16.16% |
| 2022-06-30 | 10.03% |
| 2022-03-31 | 8.33% |
| 2021-12-31 | 8.17% |
| 2021-09-30 | 8.83% |
| 2021-06-30 | 8.61% |
| 2021-03-31 | 7.54% |
| 2020-12-31 | 7.56% |
| 2020-09-30 | 8.68% |
| 2020-06-30 | 10.42% |
| 2020-03-31 | 11.97% |
| 2019-12-31 | 12.19% |
| 2019-09-30 | 11.79% |
| 2019-06-30 | 11.28% |
| 2019-03-31 | 11.26% |
| 2018-12-31 | 10.19% |
| 2018-09-30 | 9.29% |
| 2018-06-30 | 7.76% |
| 2018-03-31 | 7.00% |
| 2017-12-31 | 7.45% |
| 2017-09-30 | 6.61% |
| 2017-06-30 | 7.55% |
| 2017-03-31 | 7.86% |
| 2016-12-31 | 7.05% |
| 2016-09-30 | 7.31% |
| 2016-06-30 | 6.89% |
| 2016-03-31 | 6.70% |
| 2015-12-31 | 7.33% |
| 2015-09-30 | 7.37% |
| 2015-06-30 | 7.57% |
| 2015-03-31 | 7.36% |
| 2014-12-31 | 7.96% |
| 2014-09-30 | 10.07% |
| 2014-06-30 | 11.23% |
| 2014-03-31 | 12.87% |
| 2013-12-31 | 13.17% |
| 2013-09-30 | 13.61% |
| 2013-06-30 | 13.79% |
| 2013-03-31 | 14.09% |
| 2012-12-31 | 14.87% |
| 2012-09-30 | 15.42% |
| 2012-06-30 | 15.86% |
| 2012-03-31 | 16.61% |
| 2011-12-31 | 16.88% |
| 2011-09-30 | 18.05% |
| 2011-06-30 | 18.83% |
| 2011-03-31 | 19.15% |
| 2010-12-31 | 18.61% |
| 2010-09-30 | 19.75% |
| 2010-06-30 | 20.26% |
| 2010-03-31 | 17.53% |
| 2009-12-31 | 15.39% |
| 2009-09-30 | 11.78% |
| 2009-06-30 | 10.01% |
| 2009-03-31 | 13.41% |
| 2008-12-31 | 16.31% |
| 2008-09-30 | 19.26% |
| 2008-06-30 | 19.10% |
| 2008-03-31 | 18.35% |
| 2007-12-31 | 17.16% |
| 2007-09-30 | 14.55% |
| 2007-06-30 | 13.02% |
| 2007-03-31 | 12.60% |
| 2006-12-31 | 13.50% |
| 2006-09-30 | 11.78% |
| 2006-06-30 | 9.03% |
| 2006-03-31 | 7.38% |
| 2005-12-31 | 4.47% |
| 2005-09-30 | 4.61% |
| 2005-06-30 | 6.91% |
| 2005-03-31 | 6.38% |
| 2004-12-31 | 6.32% |
| 2004-09-30 | -4.74% |
| 2004-06-30 | -5.96% |
| 2004-03-31 | -8.48% |
| 2003-12-31 | -11.94% |
| 2003-09-30 | -3.03% |
| 2003-06-30 | -3.32% |
